CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 205 filers reported holding CHEMOCENTRYX INC in Q3 2020. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,480,000 | +63.6% | 48,000 | -21.5% | 0.01% | +83.3% |
| Q2 2022 | $1,516,000 | +72.9% | 61,171 | +74.8% | 0.01% | +100.0% |
| Q1 2022 | $877,000 | -47.3% | 34,999 | -23.4% | 0.00% | -50.0% |
| Q4 2021 | $1,664,000 | +113.1% | 45,696 | 0.0% | 0.01% | +100.0% |
| Q3 2021 | $781,000 | -44.9% | 45,696 | +65.2% | 0.00% | -50.0% |
| Q1 2021 | $1,417,000 | -17.2% | 27,655 | 0.0% | 0.01% | -25.0% |
| Q4 2020 | $1,712,000 | +13.0% | 27,655 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $1,515,000 | -4.8% | 27,655 | 0.0% | 0.01% | -11.1% |
| Q2 2020 | $1,591,000 | -8.3% | 27,655 | -36.0% | 0.01% | -25.0% |
| Q1 2020 | $1,735,000 | +8.2% | 43,187 | +6.6% | 0.01% | +50.0% |
| Q4 2019 | $1,603,000 | +117.2% | 40,528 | -62.7% | 0.01% | +100.0% |
| Q3 2019 | $738,000 | -27.1% | 108,799 | 0.0% | 0.00% | -20.0% |
| Q2 2019 | $1,012,000 | -26.6% | 108,799 | +9.6% | 0.01% | -28.6% |
| Q1 2019 | $1,379,000 | +27.3% | 99,284 | 0.0% | 0.01% | +16.7% |
| Q4 2018 | $1,083,000 | -13.7% | 99,284 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $1,255,000 | -18.9% | 99,284 | -15.5% | 0.01% | -25.0% |
| Q2 2018 | $1,548,000 | -3.1% | 117,524 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $1,598,000 | +286.0% | 117,524 | +68.8% | 0.01% | +300.0% |
| Q4 2017 | $414,000 | -19.9% | 69,613 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $517,000 | -60.4% | 69,613 | -50.0% | 0.00% | -25.0% |
| Q2 2017 | $1,304,000 | +157.2% | 139,226 | +100.0% | 0.00% | +33.3% |
| Q1 2017 | $507,000 | +11.2% | 69,613 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $456,000 | +8.6% | 69,613 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $420,000 | +34.2% | 69,613 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $313,000 | +80.9% | 69,613 | 0.0% | 0.00% | +100.0% |
| Q1 2016 | $173,000 | -71.5% | 69,613 | -7.0% | 0.00% | -75.0% |
| Q4 2015 | $606,000 | +33.8% | 74,843 | 0.0% | 0.00% | +33.3% |
| Q3 2015 | $453,000 | -26.5% | 74,843 | 0.0% | 0.00% | -25.0% |
| Q2 2015 | $616,000 | +9.0% | 74,843 | 0.0% | 0.00% | +33.3% |
| Q1 2015 | $565,000 | +10.6% | 74,843 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $511,000 | +51.6% | 74,843 | 0.0% | 0.00% | +50.0% |
| Q3 2014 | $337,000 | -23.1% | 74,843 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $438,000 | -11.7% | 74,843 | 0.0% | 0.00% | -33.3% |
| Q1 2014 | $496,000 | +1.8% | 74,843 | -11.1% | 0.00% | 0.0% |
| Q4 2013 | $487,000 | +65.1% | 84,191 | +58.7% | 0.00% | +50.0% |
| Q3 2013 | $295,000 | -71.6% | 53,064 | -27.8% | 0.00% | -66.7% |
| Q2 2013 | $1,040,000 | – | 73,521 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
| Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
| HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
| Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
| Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
| Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
| Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
| Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
| Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |